Blonder Tongue Laboratories, Inc. (BDRL)

BDRL Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018
Revenue	18.12	15.75	16.38	19.84	21.71
Revenue Growth (YoY)	14.99%	-3.82%	-17.45%	-8.59%	-6.77%
Cost of Revenue	12.65	9.9	13.36	16.41	13.29
Gross Profit	5.46	5.86	3.02	3.43	8.42
Selling, General & Admin	5.82	6.23	7.61	8.01	6.7
Research & Development	1.78	2.59	2.52	3.07	2.58
Operating Expenses	7.59	8.82	10.13	11.07	9.27
Operating Income	-2.13	-2.96	-7.11	-7.64	-0.85
Interest Expense / Income	0.79	0.51	0.35	0.26	0.56
Other Expense / Income	-	-3.57	-	-7.18	-
Pretax Income	-2.92	0.1	-7.46	-0.73	-1.42
Income Tax	0	0.02	0.02	0.02	-0.08
Net Income	-2.92	0.08	-7.47	-0.74	-1.34
Shares Outstanding (Basic)	13	12	10	10	9
Shares Outstanding (Diluted)	13	15	10	10	9
Shares Change	-14.04%	56.09%	3.07%	7.91%	8.67%
EPS (Basic)	-0.22	0.01	-0.76	-0.08	-0.15
EPS (Diluted)	-0.22	0.02	-0.76	-0.08	-0.15
Free Cash Flow	-1.43	-1.2	-3.38	2.99	0.51
Free Cash Flow Per Share	-0.11	-0.10	-0.34	0.31	0.06
Gross Margin	30.16%	37.18%	18.43%	17.29%	38.78%
Operating Margin	-11.76%	-18.79%	-43.43%	-38.51%	-3.93%
Profit Margin	-16.12%	0.53%	-45.63%	-3.74%	-6.17%
Free Cash Flow Margin	-7.89%	-7.60%	-20.62%	15.06%	2.33%
Effective Tax Rate	-	15.15%	-	-	-
EBITDA	-1.24	1.75	-6.01	0.64	-0.33
EBITDA Margin	-6.85%	11.13%	-36.71%	3.24%	-1.53%
Depreciation & Amortization	0.89	1.14	1.1	1.11	0.52
EBIT	-2.13	0.61	-7.11	-0.47	-0.85
EBIT Margin	-11.76%	3.89%	-43.43%	-2.35%	-3.93%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).